. 2022 Sep 15;9:995126. doi: 10.3389/fnut.2022.995126

TABLE 1.

Clinical chemistry data from serum samples after 12 weeks of treatment.

	CON	DMH	IMOs	DI
TP (mmol/L)	63.77 ± 4.78^ab	66.67 ± 3.05^b	62.51 ± 1.94^a	65.98 ± 1.81^b
ALB (mmol/L)	36.13 ± 3.14	35.68 ± 2.27	36.45 ± 1.07	36.56 ± 1.22
TG (mmol/L)	1.71 ± 0.49^b	0.93 ± 0.56^a	1.50 ± 0.37^ab	1.34 ± 0.69^ab
CHO (mmol/L)	2.02 ± 0.76^b	1.35 ± 0.34^a	1.48 ± 0.41^a	1.39 ± 0.17^a
HDL-C (mmol/L)	1.64 ± 0.59^b	1.15 ± 0.17^a	1.59 ± 0.32^b	1.18 ± 0.29^a
LDL-C (mmol/L)	0.36 ± 0.18^b	0.24 ± 0.05^b	0.19 ± 0.05^a	0.19 ± 0.04^a
GLU (mmol/L)	15.34 ± 2.89^b	12.96 ± 3.53^ab	11.85 ± 2.95^a	10.79 ± 3.23^a
GLO (mmol/L)	27.64 ± 1.71^a	30.99 ± 2.35^b	28.06 ± 1.81^a	29.11 ± 2.03^a

Values are presented as the mean ± s.e.m., n = 8; significant p values are presented horizontally. Significantly different values are denoted by letters.